Welcome! This is the location for news about our Division and information on our membership, governance, careers in cardiovascular pharmacology and more!

    Recent News and Announcements...

  • Congratulations to EB 2015 Division Award Winners!

    The Division for Cardiovascular Pharmacology congratulates its winners for their outstanding posters and oral sessions at EB 2015.

    2015 Benedict R. Lucchesi Distinguished Lectureship in Cardiac Pharmacology

    Andre Terzic, MD, PhD was awarded the Benedict R. Lucchesi Award in Cardiac Pharmacology on behalf of the Cardiovascular Pharmacology Division this year at Experimental Biology 2015. Dr. Terzic was recognized for the prestigious award in 2013 and was invited to deliver his state of the-art-lecture at Experimental Biology 2015 this past spring in Boston, MA.

    2015 Division for Cardiovascular Pharmacology Election Results
    Dr.Walter Koch, professor and chairperson, department of pharmacology; and director, Center for Translational Medicine, Temple University School of Medicine has been elected chair-elect of the division. Dr. Sarah Lindsey, assistant professor of pharmacology, Tulane University has been elected secretary/treasurer-elect of the division. Walter Koch 150x200  Sarah Lindsey 150x200 

    About the Division...

    The Division for Cardiovascular Pharmacology serves members with interests in all aspects of cardiovascular pharmacology research from the molecular level to whole animal studies. Specific areas include, but are not limited to, mechanisms of cardiovascular drug action, autonomic pharmacology, cell signaling, cardiac pharmacology, endothelial and smooth muscle cell pharmacology, thrombosis, blood vessel wall interactions, and mechanisms involved in the pathogenesis, diagnosis and treatment of cardiac, renal, pulmonary and cerebral vascular disease, including hypertension, coronary artery disease and stroke.